HomeMLYS • NASDAQ
add
Mineralys Therapeutics Inc
Previous close
$37.16
Day range
$36.18 - $37.99
Year range
$8.24 - $39.20
Market cap
2.80B USD
Avg Volume
2.03M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 46.75M | 3.49% |
Net income | -43.27M | -5.51% |
Net profit margin | — | — |
Earnings per share | -0.66 | 20.48% |
EBITDA | -46.73M | -3.48% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 324.92M | 4.44% |
Total assets | 335.72M | 5.41% |
Total liabilities | 22.17M | -21.92% |
Total equity | 313.55M | — |
Shares outstanding | 66.30M | — |
Price to book | 7.79 | — |
Return on assets | -33.84% | — |
Return on capital | -35.68% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -43.27M | -5.51% |
Cash from operations | -30.17M | -0.08% |
Cash from investing | -42.88M | -654.30% |
Cash from financing | 9.83M | 6,567.76% |
Net change in cash | -63.22M | -180.20% |
Free cash flow | -14.73M | 0.37% |
About
Founded
2019
Website
Employees
51
